Importer of Controlled Substances; Notice of Application; Cerilliant Corporation, 69130-69131 [2013-27454]
Download as PDF
<![CDATA[
69130
Federal Register / Vol. 78, No. 222 / Monday, November 18, 2013 / Notices
other public and private entities that
apply for COPS Office grants or
cooperative agreements will be asked
complete the COPS Application
Package. The COPS Application Package
includes all of the necessary forms and
instructions that an applicant needs to
review and complete to apply for COPS
grant funding. The package is used as a
standard template for all COPS
programs.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that 5000
respondents annually will complete the
form within 11 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated
55,000 total annual burden hours
associated with this collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Washington
DC 20530.
Dated: November 12, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2013–27467 Filed 11–15–13; 8:45 am]
BILLING CODE 4410–AT–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application: Johnson
Matthey, Inc.
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on September 5, 2013, Johnson
Matthey, Inc., Pharmaceutical Materials,
2003 Nolte Drive, West Deptford, New
Jersey 08066–1742, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
In reference to the non-narcotic raw
material, the company plans to import
gram amounts to be used as reference
standards for sale to its customers. Any
bulk manufacturer who is presently, or
is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances listed in
schedules I or II, which fall under the
authority of section 1002(a)(2)(B) of the
Act (21 U.S.C. 952(a)(2)(B)) may, in the
circumstances set forth in 21 U.S.C.
958(i), file comments or objections to
the issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODW), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than December 18, 2013.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745, all applicants for
registration to import a basic class of
any controlled substance in schedules I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. § 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: November 4, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–27448 Filed 11–15–13; 8:45 am]
BILLING CODE 4410–09–P
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug
Schedule
Coca Leaves (9040) .....................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Noroxymorphone (9668) ..............
Poppy Straw Concentrate (9670)
II
II
II
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
The company plans to import the
listed controlled substances as raw
materials, to be used in the manufacture
of bulk controlled substances, for
distribution to its customers.
VerDate Mar<15>2010
17:33 Nov 15, 2013
Jkt 232001
Importer of Controlled Substances;
Notice of Application; Cerilliant
Corporation
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on July 16, 2013, Cerilliant
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402, made
application to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
Drug
Methaqualone (2565) ...................
JWH–250 (6250) ..........................
SR–18 also known as RCS–8
(7008).
XLR11 (7011) ...............................
JWH–019 (7019) ..........................
AKB48 (7048) ...............................
JWH–081 (7081) ..........................
SR–19 also known as RCS–4
(7104).
JWH–122 (7122) ..........................
UR–144 (7144) .............................
AM–2201 (7201) ...........................
JWH–203 (7203) ..........................
Parahexyl (7374) ..........................
2C–T–2 (7385) .............................
JWH–398 (7398) ..........................
5-Methoxy-3,4-methylenedioxyamphetamine (7401).
N-Hydroxy-3,4-methylenedioxyamphetamine (7402).
Bufotenine (7433) .........................
N-Ethyl-1-phenylcyclohexylamine
(7455).
1-(1-Phenylcyclohexyl)pyrrolidine
(7458).
1-(1-Phenylcyclohexyl)pyrrolidine
(7470).
2C–D (7508) .................................
2C–E (7509) .................................
2C–H (7517) .................................
2C–I (7518) ..................................
2C–C (7519) .................................
2C–N (7521) .................................
2C–P (7524) .................................
2C–T–4 (7532) .............................
AM–694 (7694) .............................
Codeine methylbromide (9070) ....
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Benzethidine (9606) .....................
Betacetylmethadol (9607) ............
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Hydroxypethidine (9627) ..............
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Para-Fluorofentanyl (9812) ..........
3-Methylfentanyl (9813) ................
Alpha-methylfentanyl (9814) ........
Acetyl-alpha-methylfentanyl
(9815).
Beta-hydroxyfentanyl (9830) ........
Beta-hydroxy-3-methylfentanyl
(9831).
Alpha-methylthiofentanyl (9832) ...
3-Methylthiofentanyl (9833) ..........
Thiofentanyl (9835) ......................
Lisdexamfetamine (1205) .............
Glutethimide (2550) ......................
Nabilone (7379) ............................
E:\FR\FM\18NON1.SGM
18NON1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
69131
Federal Register / Vol. 78, No. 222 / Monday, November 18, 2013 / Notices
Schedule
Drug
mstockstill on DSK4VPTVN1PROD with NOTICES
1-Phenylcyclohexylamine (7460)
1-Piperidinocyclohexane
carbonitrile (8603).
Alphaprodine (9010) .....................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Noroxymorphone (9668) ..............
Racemethorphan (9732) ..............
Remifentanil (9739) ......................
Carfentanil (9743) .........................
Tapentadol (9780) ........................
DEPARTMENT OF JUSTICE
II
II
Drug Enforcement Administration
Importer of Controlled Substances,
Notice of Registration, Chattem
Chemicals, Inc.
Dated: November 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–27481 Filed 11–15–13; 8:45 am]
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances for
manufacture and distribution to their
research and forensic customers
conducting drug testing and analysis.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substance listed in schedules I and II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODW), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than December 18, 2013.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import a basic classes of
any controlled substances in schedules
I or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: November 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–27454 Filed 11–15–13; 8:45 am]
By Notice dated August 15, 2013, and
published in the Federal Register on
August 26, 2013, 78 FR 52801, Chattem
Chemicals, Inc., 3801 St. Elmo Avenue,
Chattanooga, Tennessee 37409, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
Methamphetamine (1105) ............
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
17:33 Nov 15, 2013
Jkt 232001
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers. The company
plans to import an intermediate form of
Tapentadol (9780); and then to bulk
manufacture Tapentadol for distribution
to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a) and determined
that the registration of Chattem
Chemicals, Inc., to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Chattem Chemicals,
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
BILLING CODE 4410–09–P
VerDate Mar<15>2010
II
II
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Catalent CTS,
LLC
By Notice dated August 15, 2013, and
published in the Federal Register on
August 26, 2013, 78 FR 53800, Catalent
CTS, LLC., 10245 Hickman Mills Drive,
Kansas City, Missouri 64137, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following classes of
controlled substances:
Drug
Marihuana (7360) .........................
Poppy Straw Concentrate (9670)
Schedule
I
II
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form for a clinical trial study. In
addition, the company plans to import
an ointment for the treatment of wounds
which contains trace amounts of the
controlled substances normally found in
poppy straw concentrate for packaging
and labeling to be used in clinical trials.
Comments and requests for any
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417 (2007).
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a) and determined
that the registration of Catalent CTS,
LLC., to import the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated Catalent CTS, LLC., that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Pages 69130-69131]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27454]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application;
Cerilliant Corporation
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on July 16, 2013, Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78665-2402, made application to the
Drug Enforcement Administration (DEA) for registration as an importer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methaqualone (2565)........................ I
JWH-250 (6250)............................. I
SR-18 also known as RCS-8 (7008)........... I
XLR11 (7011)............................... I
JWH-019 (7019)............................. I
AKB48 (7048)............................... I
JWH-081 (7081)............................. I
SR-19 also known as RCS-4 (7104)........... I
JWH-122 (7122)............................. I
UR-144 (7144).............................. I
AM-2201 (7201)............................. I
JWH-203 (7203)............................. I
Parahexyl (7374)........................... I
2C-T-2 (7385).............................. I
JWH-398 (7398)............................. I
5-Methoxy-3,4-methylenedioxy-amphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxy-amphetamine I
(7402).
Bufotenine (7433).......................... I
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)... I
1-(1-Phenylcyclohexyl)pyrrolidine (7470)... I
2C-D (7508)................................ I
2C-E (7509)................................ I
2C-H (7517)................................ I
2C-I (7518)................................ I
2C-C (7519)................................ I
2C-N (7521)................................ I
2C-P (7524)................................ I
2C-T-4 (7532).............................. I
AM-694 (7694).............................. I
Codeine methylbromide (9070)............... I
Acetylmethadol (9601)...................... I
Allylprodine (9602)........................ I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Alphameprodine (9604)...................... I
Alphamethadol (9605)....................... I
Benzethidine (9606)........................ I
Betacetylmethadol (9607)................... I
Betameprodine (9608)....................... I
Betamethadol (9609)........................ I
Betaprodine (9611)......................... I
Hydroxypethidine (9627).................... I
Noracymethadol (9633)...................... I
Norlevorphanol (9634)...................... I
Normethadone (9635)........................ I
Para-Fluorofentanyl (9812)................. I
3-Methylfentanyl (9813).................... I
Alpha-methylfentanyl (9814)................ I
Acetyl-alpha-methylfentanyl (9815)......... I
Beta-hydroxyfentanyl (9830)................ I
Beta-hydroxy-3-methylfentanyl (9831)....... I
Alpha-methylthiofentanyl (9832)............ I
3-Methylthiofentanyl (9833)................ I
Thiofentanyl (9835)........................ I
Lisdexamfetamine (1205).................... II
Glutethimide (2550)........................ II
Nabilone (7379)............................ II
[[Page 69131]]
1-Phenylcyclohexylamine (7460)............. II
1-Piperidinocyclohexane carbonitrile (8603) II
Alphaprodine (9010)........................ II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Noroxymorphone (9668)...................... II
Racemethorphan (9732)...................... II
Remifentanil (9739)........................ II
Carfentanil (9743)......................... II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
manufacture and distribution to their research and forensic customers
conducting drug testing and analysis.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substance listed in schedules I and II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODW), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than December 18, 2013.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants
for registration to import a basic classes of any controlled substances
in schedules I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: November 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-27454 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P
